Shandong Weigao Group Medical Polymer Co (SHWGF) Financial Statements
Shandong Weigao Group Medical Polymer Co Financial Overview
Shandong Weigao Group Medical Polymer Co's market cap is currently $1.85B. The company's EPS TTM is $0.30; its P/E ratio is 9.09; and it has a dividend yield of 5.10%. Shandong Weigao Group Medical Polymer Co is scheduled to report earnings on March 30, 2027, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 13.39B | $ 13.09B | $ 13.23B | $ 13.62B | $ 13.15B |
| Gross Profit | $ 6.33B | $ 6.58B | $ 6.64B | $ 7.31B | $ 7.35B |
| Operating Income | $ 1.70B | $ 2.39B | $ 2.04B | $ 2.92B | $ 2.89B |
| EBITDA | $ 2.83B | $ 3.24B | $ 3.55B | $ 4.38B | $ 3.75B |
| Net Income | $ 1.61B | $ 2.07B | $ 2.00B | $ 2.76B | $ 2.28B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 9.87B | $ 8.32B | $ 7.33B | $ 7.49B | $ 7.13B |
| Total Assets | $ 36.06B | $ 34.76B | $ 33.67B | $ 33.20B | $ 30.37B |
| Total Debt | $ 5.99B | $ 4.19B | $ 4.17B | $ 4.49B | $ 4.14B |
| Net Debt | $ -3.00B | $ -3.59B | $ -2.82B | $ -2.37B | $ -2.49B |
| Total Liabilities | $ 10.23B | $ 9.42B | $ 9.68B | $ 9.75B | $ 9.46B |
| Stockholders' Equity | $ 24.12B | $ 23.75B | $ 22.45B | $ 21.67B | $ 19.27B |
| Cash Flow | |||||
| Free Cash Flow | $ 1.72B | $ 2.19B | $ 2.11B | $ 1.10B | $ 1.92B |
| Operating Cash Flow | $ 2.55B | $ 2.79B | $ 2.80B | $ 2.21B | $ 3.04B |
| Investing Cash Flow | $ -382.91M | $ -1.10B | $ -1.39B | $ -2.57B | $ -1.48B |
| Financing Cash Flow | $ -772.65M | $ -1.60B | $ -2.16B | $ -1.02B | $ -547.92M |
Currency in CNY